The impact of sofosbuvir/velpatasvir/voxilaprevir treatment on serum hyperglycemia in hepatitis C virus infections: a systematic review and meta-analysis

BACKGROUND: The combination of Sofosbuvir (SOF), velpatasvir (VEL), and voxilaprevir (VOX) is an effective, safe rescue therapy for patients with previous treatment failure. Direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) infection in diabetics with a history of hypoglycemia coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Hsuan-Yu, Lai, Hui-Hsiung, Lin, Hui-Chuan, Chen, Chung-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858431/
https://www.ncbi.nlm.nih.gov/pubmed/36655629
http://dx.doi.org/10.1080/07853890.2023.2168745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858431/
https://www.ncbi.nlm.nih.gov/pubmed/36655629
http://dx.doi.org/10.1080/07853890.2023.2168745

Ejemplares similares